MyCap Mobile Application for Tracking Time Burden of Treatment for Patients With Pancreatic Cancer
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Electronic Health Record Review, Smartphone Application-based Intervention, Survey Administration.
- Who it may be relevant to
- Registry conditions: Pancreatic Adenocarcinoma. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
A Mobile App for Tracking Time Burden of Pancreatic Cancer Treatment: A Single-Arm Feasibility Study
Overview
This clinical trial tests the feasibility of using the MyCap mobile application (app) for tracking time burden from treatment for patients with pancreatic cancer. Pancreatic cancer is best treated with many care teams, such as medical oncology and surgery, requiring patients to dedicate significant time coordinating appointments among different doctors. This time commitment is referred to as time toxicity, defined as the time spent undergoing cancer-related medical care, such as emergency visits, ambulatory care, lab and infusion visits, hospitalizations, and the commuting and waiting times associated with each. At present, time toxicity is still understudied within the medical literature, with no gold standard established for the method of measurement. The MyCap mobile app may be a feasible way to track the time burden from treatment for patients with pancreatic cancer.
Detailed description
PRIMARY OBJECTIVE:
I. To assess the feasibility of utilizing a mobile application for patients to self-track the time burden associated with undergoing pancreatic cancer treatment.
OUTLINE:
Patients download the MyCap app onto their phone and fill out a daily time log in the app for 8 weeks.
Interventions
- Other Electronic Health Record Review
Ancillary studies - Behavioral Smartphone Application-based Intervention
Receive access to MyCap application - Other Survey Administration
Ancillary studies
Primary outcome measures
- Retention rate (feasibility) [Time frame: Up to 8 weeks]
- Adherence rate (feasibility) [Time frame: Up to 8 weeks]
- System usability survey (feasibility) [Time frame: Up to 8 weeks]
Eligibility criteria
Inclusion criteria
- Adults ≥ 18 years old
- Diagnosed with pancreatic adenocarcinoma undergoing active treatment or planning to start active treatment within the next 30 days
- English speaking
- Access to a smartphone (Android or iOS)
Exclusion criteria
- Prisoners
- Patients undergoing cancer surveillance
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Health services research
Study locations
United States · 1 center
- Ohio State University Comprehensive Cancer Center — Columbus
Identifiers
NCT: NCT07619391 · OSU-23326 · NCI-2026-03436 · 2020C0221